Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Rights groups condemn Israel Police decision to ban Sudan Genocide protests nationwide - 2An Excursion Through Renowned Western Network programs
- 34 African Vacationer Locations
- 44 buzzy new TV shows to watch — plus the return of 'The Comeback,' 'Jury Duty' and more
- 5Improving as a Pioneer: Examples from My Vocation
- Haunting Giant Squid Surfaces in Japan and Devours Its Prey (Video)
- Ukraine confirms defence and energy ministers at second attempt
- Expert advice for new stargazers: How to begin your amateur astronomy journey
- Grasping the Basics of Business Land Regulation
- Avoid Large Crowds In Bali & Swim At This Peaceful Waterfall With A Gorgeous, Natural Pool
- Grass Care Administrations for a Wonderful, Sound Yard
- Sudan war ‘being fought on women’s bodies’: Survivors detail sexual assault
- Recalled "super greens" supplement linked to dozens of salmonella cases, CDC says
- Vote In favor of Your Favored Comupter Game
